Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a fibrosis index including hepatitis B virus basal core promoter A1762T mutation for pretherapeutic evaluation.

Journal of gastroenterology and hepatology - 1 Aug 2018

Yeh Christopher Sung-Huan, Hsu Chao-Wei, Liang Kung-Hao, Chen Yi-Cheng, Lin Chih-Lang, Chien Rong-Nan, Hu Tsung-Hui, Lin Wey-Ran, Lai Ming-Wei, Chu Yu-De, Yeh Chau-Ting

Abstract excerpt

BACKGROUND AND AIM: Commonly used non-invasive fibrosis scores usually included serum transaminase levels in the equations, including Aspartate transaminase to Platelet Ratio Index (APRI) and fibrosis-4 (FIB-4). Transaminases fluctuated significantly in chronic hepatitis B patients with exacerbations, leading to unsteady score values. As such, here, we aim to develop a transaminase-free score suitable for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspartate Aminotransferases
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibrosis

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Liver Cirrhosis

Share to Platelet Count

Source

Identifiers

PMID: 29424069
DOI: 10.1111/jgh.14120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a fibrosis index including hepatitis B virus basal core promoter A1762T mutation for pretherapeutic evaluation.PMID 29424069Read ↗

A Multi-Biomarker Prediction Model Integrating Genetics, Hematological Indices, and Fibrosis Stage to Forecast Non-Response in HCV Genotype 4Semantic proximity Read ↗

Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.Semantic proximity Read ↗

Validity of a seven-gene signature as a non-invasive biomarker for cirrhosis: a cross-sectional study in Egyptian patients with HBV infection.Semantic proximity Read ↗

Development of hepatocellular carcinoma in chronic hepatitis B patients with advanced fibrosis is independent of viral genotype.Semantic proximity Read ↗

Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 update.Semantic proximity Read ↗

Associations between hepatitis B virus basal core promoter/pre-core region mutations and the risk of acute-on-chronic liver failure: a meta-analysis.Semantic proximity Read ↗

Mutations in basal core promoter is associated with significant fibrosis in both HBeAg positive and negative treatment-naïve chronic hepatitis B.Semantic proximity Read ↗

Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.Semantic proximity Read ↗

Impacts of the Percentage of Basal Core Promoter Mutation on the Progression of Liver Fibrosis After Hepatitis B e Antigen Seroconversion.Semantic proximity Read ↗

PNPLA3 and IL 28B signature for predicting susceptibility to chronic hepatitis C infection and fibrosis progression.Semantic proximity Read ↗

Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?Semantic proximity Read ↗

Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.